Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.
More Latest News
April 17, 2018
Click here to view a full list of bill summaries from the 2018 Florida Legislative Session that may impact your profession. Continue reading
April 15, 2018
The Quarterly Performance Report for the first quarter of the 2017-2018 fiscal year is now available online. Continue reading